Vis enkel innførsel

dc.contributor.authorEide, Per Kristian
dc.contributor.authorPripp, Are Hugo
dc.contributor.authorRingstad, Geir
dc.contributor.authorValnes, Lars Magnus
dc.date.accessioned2022-03-01T07:54:55Z
dc.date.available2022-03-01T07:54:55Z
dc.date.created2022-01-22T12:48:52Z
dc.date.issued2021-03-21
dc.identifier.citationBrain Communications. 2021, 3 (2), 1-14.en_US
dc.identifier.issn2632-1297
dc.identifier.urihttps://hdl.handle.net/11250/2981911
dc.description.abstractIdiopathic intracranial hypertension is a brain disease incorporating cerebrospinal fluid disturbance, increased intracranial pressure and visual failure, but with unknown cause. This study examined a hypothesis that glymphatic function is impaired in idiopathic intracranial hypertension patients. The MRI contrast agent gadobutrol was utilized as a cerebrospinal fluid tracer following intrathecal administration. Consecutive standardized T1 MRI acquisitions over 48 h were done to assess tracer distribution within brain of 15 idiopathic intracranial hypertension patients and 15 reference individuals who were comparable in age and gender distribution. Using FreeSurfer software, we semi-quantified tracer level in multiple brain regions as T1 MRI signal change. The tracer enriched the entire brain of idiopathic intracranial hypertension and reference subjects. In idiopathic intracranial hypertension, tracer enrichment was increased and clearance of tracer delayed from a wide range of brain regions, including both grey and white matter. Differences were most evident in frontal and temporal regions. The pulsatile intracranial pressure was measured overnight and tracer propagation in brain compared between individuals with pathological and normal pulsatile intracranial pressure. In individuals with pathological pulsatile intracranial pressure, tracer enrichment was stronger and clearance from brain delayed, particularly in regions nearby large artery trunks at the brain surface. The present in vivo observations provide evidence for impaired glymphatic function in several brain regions of idiopathic intracranial hypertension patients. Glymphatic failure may imply altered clearance of metabolic byproducts, which may precede neurodegeneration. Further studies are needed to characterize glymphatic failure in idiopathic intracranial hypertension.en_US
dc.description.sponsorshipThis work was supported by grants from Health South-East, Norway (grants 2020068), and from Department of Neurosurgery, Oslo University Hospital-Rikshospitalet, Oslo, Norway.en_US
dc.language.isoengen_US
dc.publisherOxford University Pressen_US
dc.relation.ispartofseriesBrain Communications;Volume 3, Issue 2
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.subjectIdiopathic intracranial hypertensionen_US
dc.subjectGlymphatic systemsen_US
dc.subjectCerebrospinal fluidsen_US
dc.subjectMRIen_US
dc.subjectPulsatile intracranial pressureen_US
dc.titleImpaired glymphatic function in idiopathic intracranial hypertensionen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.description.versionpublishedVersionen_US
dc.rights.holder© The Author(s) (2021)en_US
dc.source.articlenumberfcab043en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doihttps://doi.org/10.1093/braincomms/fcab043
dc.identifier.cristin1987746
dc.source.journalBrain Communicationsen_US
dc.source.volume3en_US
dc.source.issue2en_US
dc.source.pagenumber1-14en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal